Souhaitez-vous accéder aux communiqués récents ?

Abvance presents first-in-human data on insulin-glucagon co-dosing in T1D, demonstrating a novel approach to help prevent hypoglycemia

                PolTREG Establishes U.S. Subsidiary Immuthera to Advance International Development Strategy PolTREG established Immuthera (https://immuthera.bio/) in Delaware to expand its...

June 4, 2025 Biodexa Announces Recruitment of First Patient in Phase 2 Study of Tolimidone in Type 1 Diabetes Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) (Nasdaq: BDRX), a clinical...

Dublin, May 23, 2025 (GLOBE NEWSWIRE) -- The "Blood Glucose Monitoring (BGM) Devices - A Global Market Overview" has been added to ResearchAndMarkets.com's offering. This comprehensive report...

Dublin, March 07, 2025 (GLOBE NEWSWIRE) -- The "Insulin Pen Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to ResearchAndMarkets.com's...

Dublin, Feb. 04, 2025 (GLOBE NEWSWIRE) -- The "Type 1 Diabetes: 68-Market Analysis and Sales Forecast" report has been added to ResearchAndMarkets.com's offering.This report covers the 68...

Dublin, Jan. 28, 2025 (GLOBE NEWSWIRE) -- The "Smart Insulin Pens and Pumps - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...

Dublin, Jan. 20, 2025 (GLOBE NEWSWIRE) -- The "Diabetic Socks Market Size, Share & Trends Analysis by Product, Distribution Channel, and Region, 2025-2030" report has been added to ...

Dublin, Jan. 16, 2025 (GLOBE NEWSWIRE) -- The "United States Continuous Glucose Monitoring (CGM) Market, 2025-2033" report has been added to ResearchAndMarkets.com's offering.The United States...

Beta Bionics, Inc., a leader in the development of advanced diabetes management solutions, announced that it has filed a Form S-1 with the SEC.